Montreal – December 19, 2024 – The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five McGill University Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.


Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at McGill University, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.

There is broad agreement that Homo sapiens originated in Africa. But there remain many uncertainties and competing theories about where, when, and how.

What drives crocodile evolution? Is climate a major factor or changes in sea levels? Determined to find answers to these questions, researchers from McGill University discovered that while changing temperatures and rainfall had little impact on the crocodiles’ gene flow over the past three million years, changes to sea levels during the Ice Age had a different effect.

McGill University researchers have chemically imprinted polymer particles with DNA strands – a technique that could lead to new materials for applications ranging from biomedicine to the promising field of “soft robotics.”
In a study published in Nature Chemistry, the researchers describe a method to create asymmetrical polymer particles that bind together in a spatially defined manner, the way that atoms come together to make molecules.

By Tod Hoffman, Lady Davis Institute
Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform

By Chris Chipello, McGill Newsroom
Could a cheap molecule used to disinfect swimming pools provide the key to creating a new form of DNA nanomaterials?

By Cynthia Lee, McGill Newsroom
It’s not unusual for siblings to seem more dissimilar than similar: one becoming a florist, for example, another becoming a flutist, and another becoming a physicist.

By Cynthia Lee
Newsroom
Chronic pain may reprogram the way genes work in the immune system, according to a new study by McGill University researchers published in the journal Scientific Reports.

Gold nanoparticles have unusual optical, electronic and chemical properties, which scientists are seeking to put to use in a range of new technologies, from nanoelectronics to cancer treatments.

Discovery of how environmental memories may be transmitted from a man to his grandchildren

Imagine taking strands of DNA – the material in our cells that determines how we look and function – and using it to build tiny structures that can deliver drugs to targets within the body or take electronic miniaturization to a whole new level.

Researchers at McGill University have developed a new, low-cost method to build DNA nanotubes block by block – a breakthrough that could help pave the way for scaffolds made from DNA strands to be used in applications such as optical and electronic devices or smart drug-delivery systems.

Nanoscale “cages” made from strands of DNA can encapsulate small-molecule drugs and release them in response to a specific stimulus, McGill University researchers report in a new study.
The research, published online Sept. 1 in Nature Chemistry, marks a step toward the use of biological nanostructures to deliver drugs to diseased cells in patients. The findings could also open up new possibilities for designing DNA-based nanomaterials.
